Effect of an Online Reimbursement Application System on Prescribing of Lidocaine 5% Medicated Plaster in the Republic of Ireland
| Autor: | Cormac Kennedy, Michael J. Barry, Amelia Smith, Maria Daly, Stephen Doran |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Economics and Econometrics
medicine.medical_specialty education.field_of_study Health economics Lidocaine business.industry 030503 health policy & services Health Policy Population Pharmacy General Medicine General medical services Health administration 03 medical and health sciences 0302 clinical medicine Emergency medicine medicine 030212 general & internal medicine Medical prescription 0305 other medical science business education Reimbursement medicine.drug |
| Zdroj: | Applied Health Economics and Health Policy. 19:133-140 |
| ISSN: | 1179-1896 1175-5652 |
| DOI: | 10.1007/s40258-020-00586-5 |
| Popis: | The lidocaine 5% medicated plaster, Versatis®, has one therapeutic indication listed on the Summary of Product Characteristics—symptomatic relief of post-herpetic neuralgia (PHN) in adults. Increased expenditure on Versatis® suggests that there is considerable off-label use. To support the appropriate use of Versatis®, the Health Service Executive’s Primary Care Reimbursement Service (PCRS) introduced a reimbursement application system for Versatis® from 1 September 2017. The aim of this study was to investigate the effect of introducing a reimbursement application system on Versatis® prescribing under the General Medical Services (GMS) scheme. This study was carried out using prescription dispensing data from the PCRS pharmacy claims database. We carried out segmented linear regression to assess changes in the Versatis® prescribing rate per 1000 GMS eligible population, before and after the introduction of the online reimbursement application system. The results of the segmented regression analysis show that there was a statistically significant level (− 4.91, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink